Literature DB >> 10444778

[Assessment of renal resistance index in children with vesico-ureteral reflux].

F Frauscher1, C Radmayr, A Klauser, G Helweg, B Amort, D zur Nedden, G Bartsch.   

Abstract

AIM: To assess the value of the renal resistive index (RI) in evaluating renal perfusion in children with vesicoureteral reflux (VUR).
METHOD: We investigated 92 kidneys in 46 children with VUR with a mean age of 6 +/- 4 years. The RI was measured at the level of the interlobar-/arcuate-arteries using a color Doppler unit Acuson 128 XP/10 (Mountain View, Cal.). The results of the RI-measurement were correlated to the findings in renal scintigraphy.
RESULTS: Children with VUR grade I-III showed RI-values less than the normal physiological upper limit of 0.7. Patients with VUR grade IV-V demonstrated a significant increased RI-value of 0.77 +/- 0.07 (p < 0.0001). The correlation of the RI-measurements with the scintigraphic findings revealed a correlation-coefficient of r2 = 0.61.
CONCLUSION: Changes of renal perfusion were only found in high-grade VUR, demonstrating a good correlation with the scintigraphic findings. Therefore color Doppler ultrasound seems to be helpful in the follow-up of patients with high-grade reflux.

Entities:  

Mesh:

Year:  1999        PMID: 10444778     DOI: 10.1055/s-1999-14243

Source DB:  PubMed          Journal:  Ultraschall Med        ISSN: 0172-4614            Impact factor:   6.548


  2 in total

1.  Color-Doppler sonographic tissue perfusion measurements reveal significantly diminished renal cortical perfusion in kidneys with vesicoureteral reflux.

Authors:  T M Scholbach; C Sachse
Journal:  Indian J Nephrol       Date:  2016 Mar-Apr

2.  Color Doppler dynamic tissue perfusion measurement: a novel tool in the assessment of renal parenchymal perfusion in children with vesicoureteral reflux.

Authors:  Magdalena M Woźniak; Thomas M Scholbach; Jakob Scholbach; Agata Pawelec; Paweł Nachulewicz; Andrzej P Wieczorek; Agnieszka Brodzisz; Maria M Zajączkowska; Halina Borzęcka
Journal:  Arch Med Sci       Date:  2015-05-29       Impact factor: 3.318

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.